Kimberly-Clark Corp
Exchange: NASDAQSector: Consumer DefensiveIndustry: Household & Personal Products
Kimberly-Clark Corporation (Kimberly Clark) is a global company focused on the world in essentials for a better life through product innovation and building its personal care, consumer tissue, K C professional and health care brands. The Company is principally engaged in the manufacturing and marketing of a wide ranges of products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens and absorbency. Its operating segments include Personal Care , Consumer Tissue K C Professional and HealthCare. The Company operates and markets its products globally in Asia, Latin America, Eastern Europe, the Middle East and Africa, with a particular emphasis in China, Russia and Latin America. In April 2013, it announced the acquisition of the anesthesia business of Life-Tech, Inc.
Did you know?
Profit margin stands at 12.8%.
Current Price
$97.67
-0.77%GoodMoat Value
$93.54
4.2% overvaluedProfile
Valuation (TTM)
Market Cap$32.42B
P/E15.30
EV$39.48B
P/B21.58
Shares Out331.92M
P/Sales1.96
Revenue$16.56B
EV/EBITDA10.30
Kimberly-Clark Corp (KMB) Stock Analysis
GoodMoat Analysis
Kimberly-Clark is a leading consumer staples company with a strong brand portfolio, but it shows mixed signals for a value investor. While it possesses a moderate competitive moat and offers a high dividend, its valuation appears fair and the business faces challenges with growth and leverage.
Read full analysis
Kimberly-Clark (KMB) is a global manufacturer of essential household and personal care products, including brands like Kleenex, Huggies, and Scott. Applying the GoodMoat framework, the company demonstrates a moderate competitive moat, likely scoring in the 5-6 range. Key advantages include strong brand recognition and scale in its niche, which create pricing power and high customer loyalty—classic traits of a wide-moat consumer staples firm. Its return on equity of 134.6% is exceptionally high, though this is significantly amplified by its substantial financial leverage, as indicated by a Debt/Equity ratio of 4.77. The company's quality is mixed: it generates solid free cash flow (5.0% yield) and pays a reliable 5.03% dividend, but it shows no revenue growth (-0.6% YoY) and carries a heavy debt load. According to the Decision Framework, the business likely passes the initial Moat & Quality Gate but enters the Valuation & Risk Gate with caution. The current price of $99.36 is close to the GoodMoat Target of $93.54, suggesting a marginal or minimal margin of safety. The high leverage and lack of growth are notable red flags that offset the stability of its cash flows and dividend. For a value investor, KMB represents a stable, income-generating business trading near its estimated fair value, warranting further investigation primarily for its yield and defensive characteristics, but not presenting a clear margin-of-safety opportunity. Analysis based on data as of 2024-05-15.
Market Cap$32.42B
Current Price$97.67
P/E Ratio15.30
Forward P/E—
PEG Ratio0.90
EPS$6.07
Book Value$4.53
P/B Ratio21.58
KMB Financial Charts
FCF vs CAPEX
FCFCAPEX
Forward estimates use -1.3% FCF growth (CAGR)
Cash vs Debt
Net Debt: 6.5B
Revenue
18.4B
FY19
19.1B
FY20
19.4B
FY21
20.2B
FY22
17.1B
FY23
16.8B
FY24
16.4B
FY25
Net Income
2.2B
FY19
2.4B
FY20
1.8B
FY21
1.9B
FY22
1.8B
FY23
2.5B
FY24
2.0B
FY25
KMB 52-Week Range
$93.05
$137.73
50-Day MA: $100.05200-Day MA: $109.07
Did you know?
Trading 4% above its estimated fair value of $93.54.
Kimberly-Clark Corp (KMB) Financial Summary
Kimberly-Clark Corp (KMB) is a Consumer Defensive company in the Household & Personal Products industry, listed on NASDAQ. The stock currently trades at $97.67 with a market capitalization of $32.42B.
Key valuation metrics include a P/E ratio of 15.30, price-to-book ratio of 21.58, and EPS of $6.07. The company reports a profit margin of 12.8% and return on equity of 141.1%.
KMB Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $32.42B |
| P/E Ratio | 15.30 |
| EPS | $6.07 |
| P/B Ratio | 21.58 |
| P/S Ratio | 1.96 |
| EV/EBITDA | 10.30 |
| Dividend Yield | 5.12% |
| Profit Margin | 12.8% |
| Return on Equity | 141.1% |
| Debt/Equity | 4.77 |
KMB Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $18.45B | $2.16B |
| FY20 | $19.14B | $2.35B |
| FY21 | $19.44B | $1.81B |
| FY22 | $20.18B | $1.93B |
| FY23 | $17.15B | $1.76B |
| FY24 | $16.80B | $2.54B |
| FY25 | $16.45B | $2.02B |
Kimberly-Clark Corp (KMB) Valuation
Based on GoodMoat's DCF model, Kimberly-Clark Corp has a fair value estimate of $93.54. At the current price of $97.67, the stock appears 4.4% overvalued relative to our intrinsic value estimate.
KMB Quality Indicators
Kimberly-Clark Corp maintains a profit margin of 12.8% and an operating margin of 14.3%. Return on equity stands at 141.1%. The current ratio is 0.75. Debt-to-equity ratio is 4.77.
About Kimberly-Clark Corp
Kimberly-Clark Corporation (Kimberly Clark) is a global company focused on the world in essentials for a better life through product innovation and building its personal care, consumer tissue, K C professional and health care brands. The Company is principally engaged in the manufacturing and marketing of a wide ranges of products made from natural or synthetic fibers using advanced technologies in fibers, nonwovens and absorbency. Its operating segments include Personal Care , Consumer Tissue K C Professional and HealthCare. The Company operates and markets its products globally in Asia, Latin America, Eastern Europe, the Middle East and Africa, with a particular emphasis in China, Russia and Latin America. In April 2013, it announced the acquisition of the anesthesia business of Life-Tech, Inc.
KMB Free Cash Flow
Kimberly-Clark Corp generated $1.64B in trailing twelve-month free cash flow, representing an FCF yield of 5.06%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
KMB Shares Outstanding
Kimberly-Clark Corp has 0.33 billion shares outstanding at a share price of $97.67, giving it a market capitalization of $32.42B.
KMB Recent Insider Trades
Recent insider transactions at Kimberly-Clark Corp include:
| Insider | Type | Shares | Value |
|---|---|---|---|
| Chen Katy (President, Int'l Personal Care) | SELL | 1,405 | $136221.78 |
| MACLIN TODD | BUY | 10,000 | $1.04M |
| Scribner Andrew (Controller, VP & FP&A) | SELL | 3,049 | $317980.21 |